Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000201
Filing Date
2022-03-21
Accepted
2022-03-21 13:23:57
Documents
44
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybleu123121form10q.htm   iXBRL 10-Q 513448
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 8143
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 10097
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 4788
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 4814
  Complete submission text file 0001607062-22-000201.txt   2158285

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cik0001818674-20211231.xsd EX-101.SCH 19371
3 XBRL CALCULATION FILE cik0001818674-20211231_cal.xml EX-101.CAL 33705
4 XBRL DEFINITION FILE cik0001818674-20211231_def.xml EX-101.DEF 42528
5 XBRL LABEL FILE cik0001818674-20211231_lab.xml EX-101.LAB 145323
6 XBRL PRESENTATION FILE cik0001818674-20211231_pre.xml EX-101.PRE 118256
38 EXTRACTED XBRL INSTANCE DOCUMENT sybleu123121form10q_htm.xml XML 201641
Mailing Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001
Business Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001 6192279192
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-248059 | Film No.: 22755218
SIC: 2834 Pharmaceutical Preparations